Start-up Sentai wins UK independent living grant

Latest articles

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

X marks the spot for meaningful information on aging and cognition

Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline. A new paper published in Jama...

Most read

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Editor's picks

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

Click the globe for translations.

Machine-learning smart device uses AI to promote independence and safety.

A British technology start-up focused on helping the elderly live more independently in their own home has received financial backing from the UK Government. Accelerated by the coronavirus crisis and rising loneliness amongst the elderly, Sentai, a portable smart device using AI and Augmented Voice Technology to monitor and support older people, has received a grant from Innovate UK, the UK’s innovation agency.

Longevity.Technology:  This device concept hits the market at a time when it is estimated 1.4 million people aged 50 and over in England alone suffer from loneliness. And with the number of people in Europe aged 80 and over expected to more than double by 2070, from 29 million to over 60 million, the need to support and monitor the elderly will be crucial in a post-pandemic world.

Thanks to advancements in machine-learning capabilities, Sentai can provide a contextual experience with the user, meaning conversations feel natural rather than robotic or one way. For example, it can detect the mood of a person from their voice and centre responses around that, whilst providing timely prompts around important things such as medication.

The idea is to offer a small, discreet, personal task force to deal with the day-to-day care needs of the elderly, whilst keeping them connected to their loved ones and community. The caregiver can stay connected via a smart app, with daily performance logs and push notifications enabling them to get peace of mind.

Phil Marshman, Sentai’s CEO and founder, said: “We’re delighted to see the Government backing us under the Sustainable Innovation Fund, as it serves to underline how much our product is needed. With winter fast approaching and another national lockdown underway, loneliness is only set to rise further, and we want to be able to ensure our loved ones are monitored and supported when we can’t physically be with them.”

 


 

“We’re now one step closer to making Sentai accessible to all who need it and incredibly excited at the prospect of being able to offer a viable solution to combatting loneliness, thereby improving quality of life and ensuring peace of mind.”

 


 

He continued: “We’re now one step closer to making Sentai accessible to all who need it and incredibly excited at the prospect of being able to offer a viable solution to combatting loneliness, thereby improving quality of life and ensuring peace of mind.”

Ovarian Longevity webinar

Also, equipped with sensors, Sentai monitors movements and can call for help if someone falls, and can remind them to take medication throughout the day as needed.

Dr Ian Campbell, Executive Chair of Innovate UK, said: “In these difficult times we have seen the best of British business innovation. The pandemic is not just a health emergency but one that impacts society and the economy.

“Sentai, along with every initiative Innovate UK has supported through this fund, is an important step forward in driving sustainable economic development. Each one is also helping to realise the ambitions of hard-working people.”

Innovate UK is investing up to £191million to fund research and development projects with the aim of helping all sectors of the UK rebuild after the effects of COVID-19, the fund is supporting 1,103 projects and 1,189 UK businesses, totalling over £130million in aid.

Ovarian Longevity webinar

We recently reported how the UK’s Industrial Strategy Challenge Fund has developed a programme to promote new healthy aging solutions. The Healthy Aging Investment Accelerator is a five-year initiative to support smaller tech companies who are working to combat health issues related to the aging process, and is part of the UK Government’s commitment to developing the role technology can play in improving healthcare.

To further help get the device into the homes of people who need it, Sentai is preparing to launch a Kickstarter campaign to raise funds for the next stage of its development – the success of which will see its pioneering technology brought to mass market. Details of the Kickstarter are due to be announced imminently.

Image courtesy of Sentai
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...

Related articles

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Shifting gear: startup aims to de-risk rejuvenation therapy

Shift Bioscience raising funding to develop safe cellular reprogramming therapies for rejuvenation. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has been contracted by the...

Predicting possible Alzheimer’s with nearly 100% accuracy

Researchers develop a deep learning-based method that can predict the possible onset of Alzheimer's disease from brain images with an accuracy of over 99%. Researchers...

Longevity industry “taking shape”

ARDD 2021 kicks off: sessions to cover longevity topics from AI and senolytics to mitochondria and stem cell rejuvenation. Following yesterday’s workshops, ARDD 2021 really...

The need to educate in longevity

Lots to learn about longevity at ARDD 2021: from pharma and startups to physicians and high schoolers. This week, we’ll be bringing you a wealth...
Nutriop